Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer

PURPOSE: The effects of immune checkpoint inhibitors have been reported to be linked with immune-related adverse events (irAEs). In patients with advanced non-small-cell lung cancer, who tested positive for programmed death-ligand 1 (PD-L1), pembrolizumab, an immune checkpoint inhibitor can be used...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lung Cancer (Auckl)
Main Authors: Noguchi, Susumu, Suminaga, Keiichiro, Kaki, Takahiro, Kawachi, Hiroaki, Fukao, Akari, Terashita, Satoshi, Horikawa, Sadao, Ikeue, Tatsuyoshi, Sugita, Takakazu
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7367935/
https://ncbi.nlm.nih.gov/pubmed/32765147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S254146
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados